This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Cenerx Biopharma, Inc.. Active years: 2009-2011.
Company Filing History:
Years Active: 2009-2011
Title: Michael Rafferty: Innovator in Central Nervous System Treatments
Introduction
Michael Rafferty is a notable inventor based in Olathe, KS (US). He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of central nervous system disorders. With a total of 2 patents to his name, Rafferty's work is paving the way for advancements in medical treatments.
Latest Patents
Rafferty's latest patents focus on "Dialkylamino alkyl esters of pivagabine as medicaments for the treatment of central nervous system disorders." These embodiments relate to specific compounds that exhibit improved pharmacokinetic and therapeutic profiles compared to pivagabine. The pharmaceutical formulations derived from these compounds aim to treat a wide variety of central nervous system disorders effectively.
Career Highlights
Michael Rafferty is currently associated with Cenerx Biopharma, Inc., where he continues to innovate and develop new treatments. His expertise in pharmacology and medicinal chemistry has been instrumental in advancing therapeutic options for patients suffering from neurological conditions.
Collaborations
(Section skipped due to space constraints.)
Conclusion
Michael Rafferty's contributions to the field of pharmaceuticals, particularly in the treatment of central nervous system disorders, highlight his role as an influential inventor. His ongoing work promises to enhance the quality of life for many individuals affected by these conditions.